Trials / Completed
CompletedNCT00828906
DuoTrav® Eye Drops As Replacement Therapy Program
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 128 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the effectiveness of DuoTrav Eye Drops in gaining or maintaining control of target Intraocular Pressures (tIOP) in patients diagnosed with, and being treated for, open-angle glaucoma (OAG) or ocular hypertension (OH).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DuoTrav | DuoTrav Eye Drops |
Timeline
- Start date
- 2009-02-01
- Primary completion
- 2009-11-01
- First posted
- 2009-01-26
- Last updated
- 2012-09-20
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT00828906. Inclusion in this directory is not an endorsement.